Olanzapine use in a patient with schizophrenia and the risk of diabetes : case report

Folnegović-Šmalc, Vera; Jukić, Vlado; Kozumplik, Oliver; Mimica, Ninoslav; Uzun, Suzana

doi:10.1016/j.eurpsy.2003.09.003

Pregled bibliografske jedinice broj: 464853

Olanzapine use in a patient with schizophrenia and the risk of diabetes : case report

Folnegović-Šmalc, Vera; Jukić, Vlado; Kozumplik, Oliver; Mimica, Ninoslav; Uzun, Suzana

Olanzapine use in a patient with schizophrenia and the risk of diabetes : case report // European psychiatry, 19 (2004), 1; 62-64 doi:10.1016/j.eurpsy.2003.09.003 (međunarodna recenzija, članak, stručni)

CROSBI ID: 464853 Za ispravke kontaktirajte CROSBI podršku putem web obrasca

Naslov
Olanzapine use in a patient with schizophrenia and the risk of diabetes : case report

Autori
Folnegović-Šmalc, Vera ; Jukić, Vlado ; Kozumplik, Oliver ; Mimica, Ninoslav ; Uzun, Suzana

Izvornik
European psychiatry (0924-9338) 19 (2004), 1; 62-64

Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, stručni

Ključne riječi
olanzapine ; patient ; schizophrenia ; diabetes

Sažetak
Based on this experience, we find that glucose monitoring should be considered during treatment with olanzapine. In order to evaluate frequency of hyperglycemia, the probability of glucose elevation during olanzapine therapy, as well as the connection of hyperglycemia with olanzapine therapy, further clinical investigations are necessary.

Izvorni jezik
Engleski

Znanstvena područja
Kliničke medicinske znanosti

POVEZANOST RADA

Projekti:
0123004

Ustanove:
Medicinski fakultet, Zagreb,
Klinika za psihijatriju Vrapče

Profili:

Ninoslav Mimica (autor)